Common Stock and Stock-Based Incentive Compensation Plans (Tables)
|
12 Months Ended |
Dec. 28, 2024 |
Share-Based Payment Arrangement [Abstract] |
|
Schedule of Common Shares Outstanding |
Shares of common stock outstanding were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 28, 2024 |
|
December 30, 2023 |
|
December 31, 2022 |
|
(In millions) |
Balance, beginning of period |
1,616 |
|
|
1,612 |
|
|
1,207 |
|
Common stock issued in the acquisition of Xilinx |
— |
|
|
— |
|
|
429 |
|
Common stock issued under employee equity plans |
17 |
|
|
17 |
|
|
17 |
|
Repurchases of common stock |
(6) |
|
|
(10) |
|
|
(36) |
|
Common stock repurchases for tax withholding on equity awards |
(5) |
|
|
(4) |
|
|
(5) |
|
Issuance of common stock upon warrant exercise |
— |
|
|
1 |
|
|
— |
|
|
|
|
|
|
|
Balance, end of period |
1,622 |
|
|
1,616 |
|
|
1,612 |
|
|
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs |
Stock-based compensation expense was allocated in the Company’s Consolidated Statements of Operations as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 28, 2024 |
|
December 30, 2023 |
|
December 31, 2022 |
|
(In millions) |
Cost of sales |
$ |
21 |
|
|
$ |
30 |
|
|
$ |
29 |
|
Research and development |
1,079 |
|
|
1,002 |
|
|
697 |
|
Marketing, general, and administrative |
307 |
|
|
352 |
|
|
355 |
|
Total stock-based compensation expense before income taxes |
1,407 |
|
|
1,384 |
|
|
1,081 |
|
Income tax benefit |
(251) |
|
|
(249) |
|
|
(179) |
|
Total stock-based compensation expense, net of income taxes |
$ |
1,156 |
|
|
$ |
1,135 |
|
|
$ |
902 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The weighted-average estimated fair value of employee stock options granted during 2024, 2023 and 2022 was $68.38, $53.72 and $44.35 per share, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 28, 2024 |
|
December 30, 2023 |
|
December 31, 2022 |
Expected volatility |
54.34 |
% |
|
52.36% - 52.42% |
|
51.28 |
% |
Risk-free interest rate |
3.80 |
% |
|
3.93% - 4.11% |
|
3.00 |
% |
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
Expected life (in years) |
4.98 |
|
4.96 - 5.04 |
|
4.75 |
The weighted-average grant date fair values of PRSUs granted during 2024, 2023 and 2022 were $118.98, $134.87 and $121.12, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 28, 2024 |
|
December 30, 2023 |
|
December 31, 2022 |
Expected volatility |
52.68% - 53.19% |
|
51.12% - 56.22% |
|
50.65% - 53.51% |
Risk-free interest rate |
3.82% - 4.41% |
|
4.30% - 4.36% |
|
1.14%- 3.17% |
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
Expected term (in years) |
2.48 - 3.00 |
|
2.17 - 3.00 |
|
2.07 - 3.07 |
|
Schedule of Share-based Compensation, Stock Options, Activity |
The following table summarizes stock option activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding Number of Shares |
|
Weighted- Average Exercise Price |
|
Aggregate Intrinsic Value |
|
Weighted-Average Remaining Contractual Life (in years) |
|
(In millions, except share price) |
|
|
Balance as of December 30, 2023 |
3 |
|
|
$ |
68.33 |
|
|
|
|
|
Granted |
— |
|
|
$ |
134.27 |
|
|
|
|
|
Forfeited |
— |
|
|
$ |
102.71 |
|
|
|
|
|
Exercised |
(1) |
|
|
$ |
22.17 |
|
|
|
|
|
Balance as of December 28, 2024 |
2 |
|
|
$ |
89.73 |
|
|
$ |
81 |
|
|
3.92 |
Exercisable December 28, 2024 |
1 |
|
|
$ |
74.61 |
|
|
$ |
69 |
|
|
2.83 |
|
Schedule of Share-based Compensation, Restricted Stock Units, Activity |
The following table summarizes time-based RSU activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted- Average Grant Date Fair Value |
|
|
|
|
|
(In millions) |
|
|
|
|
|
|
Unvested shares as of December 30, 2023 |
32 |
|
|
$ |
100.65 |
|
|
|
|
|
Granted |
12 |
|
|
$ |
141.95 |
|
|
|
|
|
Forfeited |
(1) |
|
|
$ |
107.96 |
|
|
|
|
|
Vested |
(13) |
|
|
$ |
101.35 |
|
|
|
|
|
Unvested shares as of December 28, 2024 |
30 |
|
|
$ |
116.77 |
|
|
|
|
|
|
Schedule of Nonvested Performance-based Units Activity |
The following table summarizes PRSU activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted-Average Grant Date Fair Value |
|
|
|
|
|
(In millions) |
|
|
|
|
|
|
Unvested shares as of December 30, 2023 |
2 |
|
|
$ |
117.65 |
|
|
|
|
|
Granted |
1 |
|
|
$ |
118.98 |
|
|
|
|
|
Forfeited |
— |
|
|
$ |
132.80 |
|
|
|
|
|
Vested |
(1) |
|
|
$ |
91.15 |
|
|
|
|
|
Unvested shares as of December 28, 2024 |
2 |
|
|
$ |
139.31 |
|
|
|
|
|
|
Schedule of ESPP |
The weighted-average grant date fair value for the ESPP during 2024, 2023 and 2022 was $43.80, $31.11 and $24.71 per share, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 28, 2024 |
|
December 30, 2023 |
|
December 31, 2022 |
|
|
|
|
Expected volatility |
48.14% - 49.38% |
|
45.74% - 49.40% |
|
58.15% - 63.76% |
|
|
|
|
Risk-free interest rate |
4.42% - 5.41% |
|
5.13% - 5.46% |
|
1.43% - 4.52% |
|
|
|
|
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
Expected term (in years) |
0.50 |
|
0.50 |
|
0.50 |
|
|
|
|
|